These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8906592)

  • 1. A novel nonsense mutation (G181X) in the human cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects.
    Arai T; Yamashita S; Sakai N; Hirano K; Okada S; Ishigami M; Maruyama T; Yamane M; Kobayashi H; Nozaki S; Funahashi T; Kameda-Takemura K; Nakajima N; Matsuzawa Y
    J Lipid Res; 1996 Oct; 37(10):2145-54. PubMed ID: 8906592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and phenotypic spectrum of cholesteryl ester transfer protein gene mutations in Japanese hyperalphalipoproteinemia.
    Maruyama T; Sakai N; Ishigami M; Hirano K; Arai T; Okada S; Okuda E; Ohya A; Nakajima N; Kadowaki K; Fushimi E; Yamashita S; Matsuzawa Y
    Atherosclerosis; 2003 Jan; 166(1):177-85. PubMed ID: 12482565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two novel missense mutations in the CETP gene in Japanese hyperalphalipoproteinemic subjects: high-throughput assay by Invader assay.
    Nagano M; Yamashita S; Hirano K; Ito M; Maruyama T; Ishihara M; Sagehashi Y; Oka T; Kujiraoka T; Hattori H; Nakajima N; Egashira T; Kondo M; Sakai N; Matsuzawa Y
    J Lipid Res; 2002 Jul; 43(7):1011-8. PubMed ID: 12091484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequency of intron 14 splicing defect of cholesteryl ester transfer protein gene in the Japanese general population--relation between the mutation and hyperalphalipoproteinemia.
    Hirano K; Yamashita S; Funahashi T; Sakai N; Menju M; Ishigami M; Hiraoka H; Kameda-Takemura K; Tokunaga K; Hoshino T
    Atherosclerosis; 1993 Apr; 100(1):85-90. PubMed ID: 8318066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Point mutation (-69 G-->A) in the promoter region of cholesteryl ester transfer protein gene in Japanese hyperalphalipoproteinemic subjects.
    Nagano M; Yamashita S; Hirano K; Kujiraoka T; Ito M; Sagehashi Y; Hattori H; Nakajima N; Maruyama T; Sakai N; Egashira T; Matsuzawa Y
    Arterioscler Thromb Vasc Biol; 2001 Jun; 21(6):985-90. PubMed ID: 11397708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular mechanisms of cholesteryl ester transfer protein deficiency in Japanese.
    Nagano M; Yamashita S; Hirano K; Takano M; Maruyama T; Ishihara M; Sagehashi Y; Kujiraoka T; Tanaka K; Hattori H; Sakai N; Nakajima N; Egashira T; Matsuzawa Y
    J Atheroscler Thromb; 2004; 11(3):110-21. PubMed ID: 15256762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel mutations of cholesteryl ester transfer protein (CETP) gene in Japanese hyperalphalipoproteinemic subjects.
    Ohtani R; Inazu A; Noji Y; Wakasugi T; Miwa K; Tada H; Kawashiri MA; Noguchi T; Nohara A; Kobayashi J; Koizumi J; Yamagishi M; Mabuchi H
    Clin Chim Acta; 2012 Mar; 413(5-6):537-43. PubMed ID: 22122993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exon 10 skipping caused by intron 10 splice donor site mutation in cholesteryl ester transfer protein gene results in abnormal downstream splice site selection.
    Sakai N; Santamarina-Fojo S; Yamashita S; Matsuzawa Y; Brewer HB
    J Lipid Res; 1996 Oct; 37(10):2065-73. PubMed ID: 8906584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular biology and pathophysiological aspects of plasma cholesteryl ester transfer protein.
    Yamashita S; Hirano K; Sakai N; Matsuzawa Y
    Biochim Biophys Acta; 2000 Dec; 1529(1-3):257-75. PubMed ID: 11111094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic cholesteryl ester transfer protein deficiency is extremely frequent in the Omagari area of Japan. Marked hyperalphalipoproteinemia caused by CETP gene mutation is not associated with longevity.
    Hirano K; Yamashita S; Nakajima N; Arai T; Maruyama T; Yoshida Y; Ishigami M; Sakai N; Kameda-Takemura K; Matsuzawa Y
    Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1053-9. PubMed ID: 9194754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerotic disease in marked hyperalphalipoproteinemia. Combined reduction of cholesteryl ester transfer protein and hepatic triglyceride lipase.
    Hirano K; Yamashita S; Kuga Y; Sakai N; Nozaki S; Kihara S; Arai T; Yanagi K; Takami S; Menju M
    Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1849-56. PubMed ID: 7583564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two novel mutations and functional analyses of the CETP and LIPC genes underlying severe hyperalphalipoproteinemia.
    Plengpanich W; Siriwong S; Khovidhunkit W
    Metabolism; 2009 Aug; 58(8):1178-84. PubMed ID: 19428034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel mutations of CETP gene in Italian subjects with hyperalphalipoproteinemia.
    Cefalù AB; Noto D; Magnolo L; Pinotti E; Gomaraschi M; Martini S; Vigna GB; Calabresi L; Tarugi P; Averna MR
    Atherosclerosis; 2009 May; 204(1):202-7. PubMed ID: 18926541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid detection and prevalence of cholesteryl ester transfer protein deficiency caused by an intron 14 splicing defect in hyperalphalipoproteinemia.
    Inazu A; Koizumi J; Haraki T; Yagi K; Wakasugi T; Takegoshi T; Mabuchi H; Takeda R
    Hum Genet; 1993 Mar; 91(1):13-6. PubMed ID: 8454281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of exon 15 missense mutation (442D:G) in cholesteryl ester transfer protein gene in hyperalphalipoproteinemic Japanese subjects.
    Sakai N; Yamashita S; Hirano K; Menju M; Arai T; Kobayashi K; Ishigami M; Yoshida Y; Hoshino T; Nakajima N
    Atherosclerosis; 1995 Apr; 114(2):139-45. PubMed ID: 7605382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Serum apolipoprotein E-rich HDL-C levels in the subjects with hyperalphalipoproteinemia].
    Inano K; Miida T; Okada M
    Rinsho Byori; 1997 Sep; 45(9):903-7. PubMed ID: 9311266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia.
    Yamashita S; Maruyama T; Hirano K; Sakai N; Nakajima N; Matsuzawa Y
    Atherosclerosis; 2000 Oct; 152(2):271-85. PubMed ID: 10998455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New approach to pathogenesis of genetic hyperlipoproteinemias].
    Koizumi J; Inazu A; Mabuchi H
    Rinsho Byori; 1993 May; 41(5):519-26. PubMed ID: 8350515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholesteryl ester transfer protein and hyperalphalipoproteinemia in Caucasians.
    van der Steeg WA; Hovingh GK; Klerkx AH; Hutten BA; Nootenboom IC; Levels JH; van Tol A; Dallinga-Thie GM; Zwinderman AH; Kastelein JJ; Kuivenhoven JA
    J Lipid Res; 2007 Mar; 48(3):674-82. PubMed ID: 17192423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation.
    Inazu A; Brown ML; Hesler CB; Agellon LB; Koizumi J; Takata K; Maruhama Y; Mabuchi H; Tall AR
    N Engl J Med; 1990 Nov; 323(18):1234-8. PubMed ID: 2215607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.